CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Published:2009-07 Issue:2 Volume:138 Page:286-299
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Majeti Ravindra,Chao Mark P.,Alizadeh Ash A.,Pang Wendy W.,Jaiswal Siddhartha,Gibbs Kenneth D.,van Rooijen Nico,Weissman Irving L.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference46 articles.

1. Monoclonal antibody therapy of cancer;Adams;Nat. Biotechnol.,2005

2. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines;Ailles;Blood,1997

3. The SIRP family of receptors and immune regulation;Barclay;Nat. Rev. Immunol.,2006

4. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells;Blazar;J. Exp. Med.,2001

5. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat. Med.,1997

Cited by 1382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Immune control in acute myeloid leukemia;Experimental Hematology;2024-10

3. Core-shell tecto dendrimers co-deliver drug/gene for immunomodulation of macrophages and dendritic cells and checkpoint blockade-promoted breast cancer chemoimmunotherapy;Nano Today;2024-10

4. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

5. Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis;Nature Communications;2024-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3